DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+5.67%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$1.77B
AUM Growth
+$1.77B
(-10%)
Cap. Flow
-$252M
Cap. Flow
% of AUM
-14.22%
Top 10 Holdings %
Top 10 Hldgs %
36.41%
Holding
135
New
25
Increased
19
Reduced
28
Closed
30
Top Buys
| 1 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$69.3M |
| 2 |
Humana
HUM
|
$42.8M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$35.3M |
| 4 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$33.7M |
| 5 |
DaVita
DVA
|
$30.7M |
Top Sells
| 1 |
Pfizer
PFE
|
$51.8M |
| 2 |
AstraZeneca
AZN
|
$48.2M |
| 3 |
AbbVie
ABBV
|
$45M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$35.5M |
| 5 |
THOR
THORATEC CORPORATION
THOR
|
$33.2M |
Sector Composition
| 1 | Healthcare | 50.15% |
| 2 | Financials | 1.26% |
| 3 | Technology | 0.81% |
| 4 | Industrials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KERX
26
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $19.2M | 1% | 1,483,260 -2,366,036 | -61% | -$30.6M |
|
27
Centene
CNC
$14.3B
| $18.4M | 0.96% | +312,812 | New | +$18.4M |
|
28
Insmed
INSM
$28.8B
| $17.9M | 0.93% | 1,052,245 +121,495 | +13% | +$2.07M |
|
|
AGN
29
DELISTED
ALLERGAN INC
AGN
| $16.9M | 0.87% | 152,000 -32,955 | -18% | -$3.66M |
|
30
Viatris
VTRS
$12.3B
| $16.6M | 0.86% | 382,000 -396,000 | -51% | -$17.2M |
|
|
RNA
31
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
| $14.6M | 0.75% | 3,119,381 -105,143 | -3% | -$491K |
|
|
AIRM
32
DELISTED
Air Methods Corp
AIRM
| $14.3M | 0.74% | 245,292 -435,269 | -64% | -$25.4M |
|
33
Prothena Corp
PRTA
$441M
| $14M | 0.73% | +528,705 | New | +$14M |
|
34
Assertio
ASRT
$80.4M
| $13.3M | 0.69% | 1,260,661 -244,339 | -16% | -$2.59M |
|
35
Integra LifeSciences
IART
$1.18B
| $13M | 0.67% | +272,055 | New | +$13M |
|
|
NSPH
36
DELISTED
NANOSPHERE INC. COM NEW
NSPH
| $10.9M | 0.56% | 4,746,913 -396,306 | -8% | -$908K |
|
|
NSTG
37
DELISTED
NanoString Technologies, Inc.
NSTG
| $10.8M | 0.56% | 624,711 +128,061 | +26% | +$2.21M |
|
|
BDSI
38
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $10.4M | 0.54% | 1,760,725 -856,861 | -33% | -$5.05M |
|
39
MEI Pharma
MEIP
$160M
| $10M | 0.52% | 1,254,519 +432,320 | +53% | +$3.46M |
|
40
PTC Therapeutics
PTCT
$3.92B
| $9.25M | 0.48% | 545,027 -300,000 | -36% | -$5.09M |
|
|
BLUE
41
DELISTED
bluebird bio
BLUE
| $8.88M | 0.46% | 423,224 | – | – |
|
|
ZGNX
42
DELISTED
Zogenix, Inc.
ZGNX
| $8.84M | 0.46% | 2,570,000 -1,912,646 | -43% | -$6.58M |
|
|
FMI
43
DELISTED
Foundation Medicine, Inc.
FMI
| $8.24M | 0.43% | +346,018 | New | +$8.24M |
|
|
WINT
44
DELISTED
Windtree Therapeutics Inc
WINT
| $8.23M | 0.43% | 3,659,700 +2,471,700 | +208% | +$5.56M |
|
45
Alphatec Holdings
ATEC
$2.35B
| $8.01M | 0.41% | 3,982,738 | – | – |
|
46
Vanda Pharmaceuticals
VNDA
$279M
| $7.83M | 0.41% | 631,276 -188,724 | -23% | -$2.34M |
|
47
Baxter International
BAX
$12.7B
| $7.13M | 0.37% | 102,500 +87,500 | +583% | +$6.09M |
|
|
ARNA
48
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $7.12M | 0.37% | 1,216,579 | – | – |
|
49
BioCryst Pharmaceuticals
BCRX
$1.74B
| $6.6M | 0.34% | 868,570 -763,790 | -47% | -$5.8M |
|
|
LPDX
50
DELISTED
LIPOSCIENCE INC COM
LPDX
| $5.88M | 0.3% | 1,382,350 | – | – |
|